Caisse DE Depot ET Placement DU Quebec Has $3.31 Million Holdings in The Clorox Company (NYSE:CLX)

Caisse DE Depot ET Placement DU Quebec lessened its position in shares of The Clorox Company (NYSE:CLX - Free Report) by 30.0% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 20,313 shares of the company's stock after selling 8,687 shares during the period. Caisse DE Depot ET Placement DU Quebec's holdings in Clorox were worth $3,309,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently made changes to their positions in the company. Prospera Private Wealth LLC bought a new position in Clorox during the 3rd quarter worth $27,000. Innealta Capital LLC bought a new position in Clorox during the second quarter worth about $30,000. Trifecta Capital Advisors LLC boosted its holdings in Clorox by 139.8% in the 2nd quarter. Trifecta Capital Advisors LLC now owns 223 shares of the company's stock valued at $30,000 after purchasing an additional 130 shares during the period. Family Firm Inc. acquired a new position in shares of Clorox during the 2nd quarter worth approximately $31,000. Finally, Quarry LP increased its holdings in shares of Clorox by 99.1% during the second quarter. Quarry LP now owns 229 shares of the company's stock worth $31,000 after purchasing an additional 114 shares during the period. Institutional investors and hedge funds own 78.53% of the company's stock.

Insider Buying and Selling

In other news, EVP Angela C. Hilt sold 1,733 shares of the business's stock in a transaction that occurred on Friday, September 6th. The shares were sold at an average price of $165.52, for a total value of $286,846.16. Following the transaction, the executive vice president now owns 13,471 shares in the company, valued at approximately $2,229,719.92. The trade was a 11.40 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 0.57% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

CLX has been the topic of a number of analyst reports. Evercore ISI lowered their price objective on Clorox from $140.00 to $139.00 and set an "underperform" rating on the stock in a research note on Monday, October 14th. Barclays raised their price target on Clorox from $137.00 to $139.00 and gave the stock an "underweight" rating in a research report on Friday, November 1st. TD Cowen raised shares of Clorox from a "sell" rating to a "hold" rating and upped their price objective for the stock from $155.00 to $170.00 in a research report on Wednesday, November 6th. JPMorgan Chase & Co. raised their target price on shares of Clorox from $148.00 to $174.00 and gave the company a "neutral" rating in a report on Friday, October 11th. Finally, DA Davidson boosted their target price on shares of Clorox from $153.00 to $171.00 and gave the company a "neutral" rating in a research report on Monday, November 4th. Five equities research analysts have rated the stock with a sell rating, ten have issued a hold rating and one has assigned a buy rating to the company's stock. According to MarketBeat, the stock has a consensus rating of "Hold" and an average price target of $155.00.

Clorox Price Performance

CLX traded up $0.54 on Tuesday, reaching $167.08. The stock had a trading volume of 1,035,058 shares, compared to its average volume of 1,105,442. The company has a current ratio of 1.00, a quick ratio of 0.62 and a debt-to-equity ratio of 11.08. The company has a market capitalization of $20.68 billion, a price-to-earnings ratio of 58.22, a price-to-earnings-growth ratio of 3.08 and a beta of 0.42. The Clorox Company has a fifty-two week low of $127.60 and a fifty-two week high of $171.35. The firm has a 50-day moving average of $163.18 and a 200-day moving average of $149.90.

Clorox (NYSE:CLX - Get Free Report) last released its quarterly earnings data on Wednesday, October 30th. The company reported $1.86 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.36 by $0.50. Clorox had a return on equity of 316.08% and a net margin of 4.78%. The company had revenue of $1.76 billion during the quarter, compared to the consensus estimate of $1.64 billion. During the same quarter in the prior year, the firm posted $0.49 earnings per share. The firm's revenue was up 27.0% compared to the same quarter last year. As a group, sell-side analysts anticipate that The Clorox Company will post 6.85 EPS for the current year.

Clorox Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Wednesday, January 29th will be issued a $1.22 dividend. The ex-dividend date of this dividend is Wednesday, January 29th. This represents a $4.88 dividend on an annualized basis and a yield of 2.92%. Clorox's payout ratio is 170.04%.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.